We tested the effect of CB6644 (targeting RUVBL1/2 complex), MKT077 (inhibiting HSPA9), selinexor (blocking XPO1, nuclear exportin), and MeAIB (targeting SLC38A2) on cell lines representing three different cancer types versus the normal fibroblasts. This evidence concerns the gene RUVBL1 and cancer.